The evaluation of UPR (unfolded protein response) molecular pathway in sensitizing Glioblastoma cells to Simvastatin-TMZ combination therapy
- سال انتشار: 1400
- محل انتشار: پنجمین کنگره بین المللی سرطان
- کد COI اختصاصی: CANCERMED05_118
- زبان مقاله: انگلیسی
- تعداد مشاهده: 114
نویسندگان
Endocrine and Metabolism Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
Department of Human Anatomy and Cell Science, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R۳E ۰J۹, Canada
Department of Biochemistry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran /Autophagy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Department of Human Anatomy and Cell Science, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R۳E ۰J۹, Canada/ Autophagy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
Introduction; Chemo-resistance is a crucial barrier to effective treatment for glioblastoma (GB), the most common malignant primary brain tumor. Temozolomide (TMZ) is the first-line chemotherapeutic drug in GB; nevertheless, chemo-resistance has significantly reduced TMZ effectiveness over time. In the last decade, the combination of simvastatin (Simva), an anti-hyperlipidemic medication, alongside chemotherapy agents, have attracted more attention to improving therapeutic efficacy. Studies have demonstrated that unfolded protein response (UPR) activation followed by endoplasmic reticulum (ER) stress may impart resistance to chemo-agents and contribute to treatment failure. In the current investigation, we addressed the involvement of UPR in Simva-TMZ-induced cell death. Methods: MTT assay was used for TMZ, Simva and mevalonate to find the drugs' proper dose and duration time. U۲۵۱ GB cell was pretreated with Simva (۱ μM) for ۴ h and then co-treated with TMZ (۱۰۰ μM) for ۷۲ h. To assess the status of cell death, flow cytometry PI assay was performed. To detect markers of UPR, western blot analysis was used with different anti-bodies (GRP۷۸, IRE-۱, XBP-۱s, ATF۶, eIF۲α, P-eIF۲α, P-H۲A, Cleaved-Caspase-۳, and GAPDH as loading control). Results: Interestingly, Simva-TMZ significantly decreased cell viability and increased apoptotic cell death independent of the mevalonate cascade. Moreover, Simva–TMZ induced UPR elements, manifesting an increase in GRP۷۸, XBP-۱ splicing, p-eIF۲α, ATF۶, and caspase-۳. Conclusion: Taken together, these results uncovered a novel role of the UPR pathway in Simva that enhances TMZ-induced cell death in U۲۵۱ cells. These results highlight a possible strategy of targeting the UPR to overcome the glioblastoma chemo-resistance.کلیدواژه ها
Glioblastoma, Simvastatin, unfolded protein response, IRE-۱, cell deathمقالات مرتبط جدید
- بازتاب دانش سنتی و باورهای عامیانه مربوط به محیط زیست در مثل ها و زبانزدهای بختیاری
- سرطان چگونه به وجود می آید؟
- آشنایی با انواع سرطان و علائم آنها، راه های تشخیص و درمان
- Deciphering the Impact of the L۸۵۸R Mutation in EGFR: Computational Insights and Therapeutic Implications in Non-Small-Cell Lung Cancer
- systematic review on Investigating the relationship between obesity and breast cancer in women
اطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.